Get the Stockscreener App
3.52
8.64%
0.28
Orchestra Biomed Holdings Inc stock is traded at $3.52, with a volume of 119.87K.
It is up +8.64% in the last 24 hours and down -24.95% over the past month.
See More
Previous Close:
$3.24
Open:
$3.16
24h Volume:
119.87K
Relative Volume:
1.32
Market Cap:
$122.55M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-2.3467
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
-19.63%
1M Performance:
-24.95%
6M Performance:
-28.74%
1Y Performance:
-30.16%
1-Day Range:
$3.07
$3.60
1-Week Range:
$3.07
$4.67
52-Week Range:
$3.07
$8.8699
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.52 | 122.55M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital - Defense World
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy - MyChesCo
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Orchestra BioMed (NASDAQ:OBIO) Posts Earnings Results, Hits Estimates - MarketBeat
BTIG maintains $12 target on Orchestra BioMed stock By Investing.com - Investing.com Canada
OBIO stock touches 52-week low at $3.63 amid market challenges By Investing.com - Investing.com South Africa
OBIO stock touches 52-week low at $3.63 amid market challenges - Investing.com Australia
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - The Manila Times
(OBIO) Trading Advice - news.stocktradersdaily.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Freightos And 2 Other Penny Stocks Worth Watching - simplywall.st
Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research - ETF Daily News
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated at BTIG Research - Defense World
BTIG Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq
BTIG sets Orchestra BioMed stock with $12 target By Investing.com - Investing.com Australia
Insiders In Orchestra BioMed Holdings Left Out From 10% Price Rise After Disposing Stock - simplywall.st
BTIG Initiates Orchestra BioMed at Buy With $12 Price Target -March 20, 2025 at 07:15 am EDT - Marketscreener.com
Orchestra BioMed (OBIO) Projected to Post Earnings on Wednesday - Defense World
Orchestra BioMed (NASDAQ:OBIO) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $14 target on Orchestra BioMed stock By Investing.com - Investing.com South Africa
Promising Clinical Developments and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings - TipRanks
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MSN
Orchestra BioMed Highlights Strategic Initiatives and Innovations - TipRanks
Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN
Orchestra BioMed Updates Executive Compensation Policies - TipRanks
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire
3 Major Healthcare Conferences Where Orchestra BioMed Will Share Its Growth Story - StockTitan
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive - GlobeNewswire
Mount Sinai's Top Cardiac Expert Takes Helm of Groundbreaking Hypertension Treatment Study - StockTitan
Orchestra BioMed (NASDAQ:OBIO) Shares Up 5.1%Time to Buy? - MarketBeat
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure - MSN
SG Americas Securities LLC Has $51,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading 5.1% Higher – Here’s Why - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Decline in Short Interest - Defense World
How the (OBIO) price action is used to our Advantage - Stock Traders Daily
Individual investors among Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest stockholders and were hit after last week's 11% price drop - Simply Wall St
Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction - Marketscreener.com
Orchestra BioMed Announces Data Demonstrating Favorable - GlobeNewswire
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference - GlobeNewswire
Clinical Data: Orchestra BioMed's AVIM Therapy Shows Significant Heart Failure Prevention Benefits | OBIO Stock News - StockTitan
Orchestra BioMed Announces Appointment of Former Medtronic - GlobeNewswire
Orchestra BioMed Appoints New Director Amid Board Changes - TipRanks
Christopher Cleary Joins Orchestra BioMed Board of Directors, Enhancing Strategic Leadership in Medical Device Innovations - Nasdaq
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):